Skip to main content
. 2022 Dec 13;328(22):2242–2251. doi: 10.1001/jama.2022.21893

Table 2. Primary, Prespecified Secondary, and Post Hoc Outcomes for Patients for Whom Outcome Data Were Available at 6 Months and/or 18 Months.

Outcome measures Diet and exercise Attention control Adjusted mean difference (95% CI) P valuea
Baseline (SD) 18 Months Baseline (SD) 18 Months
Adjusted mean (95% CI) Unadjusted mean (SD) Absolute change (95% CI) Adjusted mean (95% CI) Unadjusted mean (SD) Absolute change (95% CI)
Primary outcome
WOMAC pain scoreb 7.4 (3.1) [n = 377] 5.0 (4.6-5.4) [n = 329] 5.0 (3.8) [n = 329] −2.4 (−2.8 to −2.1) 7.4 (3.1) [n = 316] 5.5 (5.1-5.9) [n = 316] 5.5 (3.7) [n = 316] −1.8 (−2.2 to −1.4) −0.6 (−1.0 to −0.1) .02
Secondary outcomes
Body weight, kg 99.6 (19.3) [n = 377] 91.4 (90.2-92.6) [n = 289] 89.8 (17.2) [n = 289] −7.7 (−8.7 to −6.7) 100.8 (22.2) [n = 343] 97.4 (96.2-98.7) [n = 273] 98.4 (21.7) [n = 273] −1.7 (−2.5 to −0.8) −6.0 (−7.3 to −4.7) <.001
Waist circumference, cmc 113 (14) [n = 376] 105 (104-107) [n = 212] 104 (14) [n = 212] −9 (−10 to −8) 115 (16) [n = 342] 111 (109-113) [n = 214] 111 (16) [n = 214] −4 (−5 to −3) −5 (−7 to −4) <.001
WOMAC function scored 25.5 (11.5) [n = 377] 16.5 (15.3-17.7) [n = 325] 16.6 (13.1) [n = 325] −9.2 (−10.5 to −7.9) 25.5 (11.4) [n = 343] 19.8 (18.6-21.0) [n = 311] 19.5 (12.6) [n = 311] −5.5 (−6.9 to −4.1) −3.3 (−4.9 to −1.7) <.001
Six-minute walk distance, me 373 (90) [n = 375] 419 (411-428) [n = 247] 427 (103) [n = 247] 41 (32 to 51) 371 (95) [n = 341] 376 (368-385) [n = 219] 375 (97) [n = 219] −4 (−12 to 4) 43 (31 to 55) <.001
Pain medication use 8.2 (5.0) [n = 377] 8.3 (7.9-8.8) [n = 231] 8.3 (5.0) [n = 231] −0.1 (−0.5 to 0.3) 8.4 (5.0) [n = 343] 8.3 (7.8-8.8) [n = 228] 8.3 (5.0) [n = 228] −0.4 (−0.8 to 0.0) 0.0 (−0.5 to 0.5) .90
Short Form 36 score (range, 0-100)f
Physical subscale 34.3 (9.2) [n = 377] 41.4 (40.2-42.6) [n = 321] 41.2 (11.1) [n = 321] 6.7 (5.6 to 7.7) 35.9 (9.1) [n = 343] 37.6 (36.3-38.8) [n = 306] 38.4 (10.6) [n = 306] 2.1 (1.2 to 3.1) 3.8 (2.5 to 5.2) <.001
Mental subscale 55.4 (9.8) [n = 377] 55.3 (54.3-56.2) [n = 321] 55.2 (9.1) [n = 321] 0.1 (−0.9 to 1.1) 55.0 (9.7) [n = 343] 54.1 (53.1-55.0) [n = 306] 54.0 (11.3) [n = 306] −1.0 (−2.4 to −0.4) 1.2 (−0.1 to 2.5) .07
Post hoc outcomes
PASE scoreg 116 (60) [n = 375] 139 (133-146) [n = 311] 138 (69) [n = 311] 23 (15 to 30) 112 (58) [n = 339] 117 (111-124) [n = 284] 114 (53) [n = 284] 1 (−6 to 8) 22 (13 to 31) <.001
CES-D scoreh 5.2 (4.8) [n = 374] 3.9 (3.2-4.7) [n = 243] 3.8 (4.2) [n = 243] −1.1 (−1.7 to −0.6) 5.5 (5.2) [n = 341] 4.6 (3.9-5.3) [n = 226] 5.0 (5.7) [n = 226] −0.4 (−1.0 to 0.3) −0.6 (−1.3 to 0.0) .07

Abbreviations: CES-D, Center for Epidemiologic Studies Depression Scale; MCID, minimum clinically important difference; MCII, minimum clinically important improvement; PASE, Physical Activity Scale for the Elderly; WOMAC, Western Ontario and McMaster Universities Osteoarthritic Index.

a

All model-adjusted estimates were created from a mixed linear model fit with treatment group, visit number, and treatment-by-visit interaction, adjusted for baseline body mass index, clinic site, sex, and baseline values of the outcome. Contrast statements were used to produce visit-specific means, mean differences, and P values.

b

Range, 0 to 20 (0, no pain; 2 to 8, mild; >8 to 14, moderate; and >14 to 20, severe); between-group MCID = 1.6, calculated as half the SD.37

c

Waist circumference thresholds (women, >88 cm; men, >102 cm) for increased health risk.29 MCID = −7.5 cm.24,37

d

Range, 0 to 68 (higher scores indicate poorer function); between-group MCID = 6.25

e

The maximum distance a participant could walk along a standardized walkway in 6 minutes. Within-group MCII, 26 m to 55 m.26

f

Health-related quality-of-life physical and mental health summary scores; range, 0 (worst) to 100 (best); within-group MCII = 5 for both physical and mental subscales.28

g

Score range, 0 to 400 (higher scores indicate more activity; MCII = 17-25).39

h

Score range, 0 to 30 (score of ≥10 indicates presence of significant depressive symptoms); MCID = 30, calculated as half the SD.36